| Name | Title | Contact Details |
|---|
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden.
CareerSource Heartland is a not-for-profit corporation that operates as a demand-driven and business focused public-private partnership. Through oversight provided by the local elected officials from DeSoto, Hardee, and Highlands counties, our Board of Directors offer workforce development related growth opportunities to Business Customers and Job Seekers throughout our Tri-County service delivery area. As one of twenty-four Regional Workforce Boards in Florida, we oversee the workforce and talent development activities in the tri-county region, collaborating with numerous private and public sector organizations and businesses to enhance the local economy. Our Board has a diversified membership with a majority of the members from the private (business) sector. The Board also includes representatives from secondary and post-secondary education institutions, Economic Development commissions, and community based organizations.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
Informatics Outsourcing is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Grason Stadler is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.